The Pharmacist

JUNE 11, 2024

The Conservative Party has set out spending plans of £250m each year on Pharmacy First from 2027 to 2030, as it pledges to expand the service to include more conditions like acne and chest infections.

Documentation 89

Documentation 89

European Pharmaceutical Review

DECEMBER 9, 2022

billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. billion by 2027 appeared first on European Pharmaceutical Review. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.

Compounding 98

Compounding 98

European Pharmaceutical Review

FEBRUARY 1, 2023

billion in 2027 at a compound annual growth rate (CAGR) of 12.5 The post Pharmaceutical sterility testing market to grow from $2.07b in 2027 appeared first on European Pharmaceutical Review. A recent market report showed that the global pharmaceutical sterility testing market is expected to grow from $2.07 billion in 2022 to $1.29

Compounding 98

Compounding 98

STAT

DECEMBER 7, 2023

One expires next year and the other in 2027, well beyond the original patent expiration date. The move meant that the company, which is now part of Bristol Myers Squibb, won several more years of valuable patent protection than it would have received had it applied for the extra patents when submitting its data to the FDA.

Drug Pricing 320

Drug Pricing Compounding Pharmaceutical Companies Pharmaceutical Companies 320

STAT

JULY 24, 2023

The House Ways & Means Committee package includes a new provision that would ensure that patients in the Medicare program pay for medicines they pick up at the pharmacy counter based on the discounted price that insurers negotiate with drugmakers, instead of higher sticker prices, starting in 2027.

Packaging 246

Packaging Drug Pricing Hospitals 246

STAT

JANUARY 17, 2023

The number of health care-related artificial intelligence models on the market has increased steadily over the past decade, with the health care AI market expected to grow from $7 billion today to $67 billion in 2027.

254

254

STAT

DECEMBER 13, 2024

The nonprofit Howard Hughes Medical Institute (HHMI) will bar institutions that already have two or more beneficiaries of its Investigator Program from applying for a round of funds to be awarded in 2027.

165

165

STAT

OCTOBER 3, 2024

1, 2025, the Centers for Medicare and Medicaid Services will select the costliest prescription medications to negotiate on, with prices coming into effect in 2027.

248

248

PharmaVoice

JULY 1, 2024

government, the latest spending projections reveal soon-to-be-implemented price caps will have an impact by 2027. As the first 10 drugs undergo price negotiations with the U.S.

130

130

STAT

JUNE 25, 2024

The company said that it expects to add 1,000 new jobs, and that construction will gradually be finalized between 2027 and 2029. Novo Nordisk said the new facility would expand over 56 acres and add 1.4 million square feet of production space, doubling the combined square footage of the other three facilities in North Carolina.

266

266

STAT

NOVEMBER 20, 2023

Under the new agreement, the level of allowed growth in drug sales will increase from 2% in 2024 to 4% by 2027. The current plan, which has drawn the ire of pharma companies, requires drug companies to pay rebates back to the U.K. if spending on medicines increases by more than 2% a year. Continue to STAT+ to read the full story…

273

273

STAT

DECEMBER 12, 2024

The company plans to begin the trial next year, with an eye toward regulatory filings in late 2027. Such a medicine, if proven effective, would be the closest thing to a vaccine the HIV field has produced in four decades of research.

Drug Pricing 251

Drug Pricing Vaccines 251

Pharmaceutical Technology

AUGUST 31, 2023

Alkermes settled the lawsuit with Teva, allowing the latter to market the generic version of Vivitrol from January 2027.

52

52

BioPharma Dive

NOVEMBER 15, 2023

The deal gives Gilead an estimated 13% ownership in Arcellx and extends the company’s cash runway into 2027.

119

119

Pharmaceutical Commerce

AUGUST 19, 2024

The 86,000 square-foot Køge facility will be fully functional by 2027.

81

81

Express Pharma

NOVEMBER 25, 2024

The Government aims to expand the reach of PMBJP by increasing the number of Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) to 25,000 by March 2027. The post Pharmaceuticals & Medical Devices Bureau of India participates in 43rd Edition of IITF 2024 appeared first on Express Pharma.

104

104

Putting Patients First Blog

JULY 2, 2024

Clarification on QALY Metrics The NHC appreciates CMS’ commitment to excluding Quality-Adjusted Life Years (QALYs) from the negotiation process as outlined in the 2027 draft guidance. Valuing life differently based on disability status, age, or other special populations is inappropriate.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing HIPAA Labelling 52

Outsourcing Pharma

OCTOBER 24, 2023

Traditionally, the pharmaceutical landscape has been dominated by small molecules.

64

64

PharmaTech

SEPTEMBER 12, 2024

Seventeen biologics and nine tides—five peptides and four oligonucleotides—were approved in 2023 alone, with further growth predicted.

52

52

Express Pharma

DECEMBER 9, 2024

15,000 crores and a production tenure from FY 2022- 2023 to FY 2027-28, provides financial incentives to 55 selected applicants for manufacturing of identified products under three categories for six years. The scheme provides financial incentives for the manufacturing of notified products. are manufactured. An incentive amount of Rs.3,215

Immunity 102

Immunity Immunization 102

Pharmaceutical Commerce

APRIL 5, 2023

Rise in value attributed to the ongoing decentralization of pharmacies.

52

52

The Guardian - Pharmaceutical Industry

SEPTEMBER 21, 2023

The commission’s investigation was made public last week by the health department and the Health Justice Initiative (HJI) legal organisation at a media briefing of Médecins Sans Frontières (MSF).

Drug Pricing 97

Drug Pricing 97

STAT

SEPTEMBER 12, 2024

billion, between 2024 and 2027 in a concession to investors who have viewed the company’s outlays following its pandemic-era windfall as profligate, STAT writes. So here are some items of interest. Have a great day, everyone. … Moderna plans to cut its annual spending on research and development by 23%, or $1.1

Packaging 146

Packaging Diabetes Vaccines 146

Pharmacy Times

JANUARY 10, 2023

The report highlights the growth of personalized medicines with improved efficacy for rare, previously untreatable diseases.

52

52

Putting Patients First Blog

SEPTEMBER 3, 2024

We strongly urge CMS to address these issues in the IPAY 2027 portal to ensure that all participants, regardless of their familiarity with technology or survey formats, can contribute their insights without unnecessary difficulty. Conclusion The NHC appreciates the opportunity to provide input on the IRA 2027 Drug Price Negotiation ICR.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling Communication 52

PharmaTech

OCTOBER 26, 2023

As CMOs continue to invest in cell culture capacity, some are expected to surpass top in-house companies.

52

52

European Pharmaceutical Review

NOVEMBER 2, 2022

Somewhat ambitious: Meet three percent of GDP by 2027, building on aspirations set out by the Confederation of British Industry (CBI), the European Commission (EC) and opposition political parties. The government would need to invest an extra £1 billion in R&D by 2027. Private investment would also need to rise by £0.8

Communication 98

Communication 98

European Pharmaceutical Review

AUGUST 27, 2024

Manufacturing of the biologic products in the expanded Sweden Biomanufacturing Center is planned to begin from Q4 of 2027, according to AstraZeneca. “We are happy about this investment in Södertälje, which demonstrates AstraZeneca’s commitment to innovation and manufacturing of biological medicines in Sweden”, Alfredsson continued.

115

115

Pharmaceutical Technology

OCTOBER 6, 2023

Biologics are poised to overtake innovative small molecules in terms of sales revenue by 2027, with forecast sales of $120bn.

59

59

Pharmaceutical Commerce

AUGUST 30, 2024

The 3PL plans to convert all its trucks to electric by 2027.

52

52

Pharmaceutical Commerce

JANUARY 25, 2023

Annual report finds continuing impact of COVID-19 on global markets

52

52

Express Pharma

NOVEMBER 5, 2024

million over a three-year period, ending on June 30, 2027, a filing showed. Under terms of the deal, the company and the UKHSA agreed to settle the outstanding amount under dispute related to upfront payments received by Novavax from the health agency. Novavax has agreed to refund $123.8 The first installment payment is due on Nov.

Vaccines 103

Vaccines 103

Pharmaceutical Technology

MAY 23, 2024

The cost saving programme is expected run over multiple years and will save the company about $1.5bn by 2027.

52

52

pharmaphorum

NOVEMBER 25, 2020

Jefferies expects that the company expects sales of $14 billion could be at risk by 2027 from patent expiries of Tasigna, Promacta, Jakavi, Gilenya and Entresto. In the short term, the analysts predict “flattish” Q4 sales, although they noted that the company may benefit from cost savings introduced during the COVID-19 pandemic.

Biosimilars 119

Biosimilars Hospitals 119

PharmaTech

OCTOBER 4, 2024

When the expansion is completed, Piramal expects manufacturing capacity to be increased by the first quarter of 2027 from 104 product batches per year to more than 240.

52

52

European Pharmaceutical Review

FEBRUARY 27, 2024

The facility has been designed to meet the highest environmental sustainability standards, to help Amgen’s reach its target of carbon neutrality in all operations by 2027, the company noted. .” Amgen Ohio is nearly 300,000 ft 2 in size and will employ 400 full-time staff.

Biosimilars 105

Biosimilars Pharmaceutical Companies Pharmaceutical Companies Drug Development 105

European Pharmaceutical Review

JUNE 26, 2024

Completion is expected between 2027 and 2029. This is compared to the company’s $3.9 (DKK DKK 26 billion) investment in 2023, not including acquisitions. Initial construction work has begun on the new facility. Haemophilia drug could reduce treated bleeding episodes … The post New US fill finish facility receives $4.1

Diabetes 104

Diabetes Pharmaceutical Companies Pharmaceutical Companies 104